INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "CRYSTALLINE FORM OF (S)-N-ETHYL-3-((9-ETHYL-2-(((2R,3S)-2-HYDROXYPENTAN-3-YL)AMINO)-9H-PURIN-6-YL)AMINO)-PYRROLIDINE-1-SULFONAMIDE"

GENEVA, Oct. 4 -- ASTRAZENECA AB (SE-151-85 Sodertalje) filed a patent application (PCT/IB2025/053301) for "CRYSTALLINE FORM OF (S)-N-ETHYL-3-((9-ETHYL-2-(((2R,3S)-2-HYDROXYPENTAN-3-YL)AMINO)-9H-PURIN-6-YL)AMINO)-PYRROLIDINE-1-SULFONAMIDE" on Mar 28, 2025. With publication no. WO/2025/202991, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Dedong (c/o ASTRAZENECA PHARMACEUTICALS LP1800 Concord Pike, P.O. Box 15437Wilmington, Delaware 19850-5437)

Abstract: Crystalline form of N-ethyl-3-((9-ethyl-2-(((2R,3S)-2-hydroxyp...